As the neutrophil granulocyte plays an important part in rheumatoid inflammation the effect of sulphasalazine on neutrophil function was studied. The results show that sulphasalazine, and its metabolite sulphapyridine, inhibit neutrophil superoxide production elicited by the receptor mediated stimulus N-formyl-methionyl-leucyl-phenylalanine (fMLP) and by the calcium ionophore A23187. This effect seems to be dependent on inhibition of intracellular Ca"+ increase as both substances reduce this increase upon cell activation with fMLP and A23187. Sulphasalazine and sulphapyridine do not inhibit superoxide production after stimulation with the ester phorbol myristate acetate, a stimulus response coupling which is independent of intracellular Ca++ increase. The reported inhibition of superoxide generation may explain, at least partly, the antirheumatic property of sulphasalazine.
Sulphasalazine is now widely accepted as a disease modifying drug in the treatment of rheumatoid arthritis. '`The mechanisms by which sulphasalazine exerts its antirheumatic properties are largely unknown, however, and it is also unclear which part of the molecule is active.
Less than 300/o of ingested sulphasalazine is absorbed in the small intestine.6 7 The remaining drug is cleaved by colonic bacteria into sulphapyridine and 5-aminosalicylic acid.6 8 9 Sulphapyridine is almost totally absorbed whereas 5-aminosalicylic acid largely is retained in the colon and can only be detected in serum in very small amounts.7-'0 In the colon 5-aminosalicylic acid is present in high concentrations and has been considered to be the therapeutic moiety of sulphasalazine in ulcerative colitis.1 ' 12 In rheumatoid arthritis, on the other hand, it has during the last years been proposed that sulphapyridine or sulphasalazine, or both, are responsible for the antirheumatic activity.'3 14 Suggested explanations for this activity include antibacterial effect in the colon'5 or immunosuppressive activity.""'9 Sulphasalazine also interferes with prostaglandin metabolism.20 21 A further proposal is that sulphasalazine or sulphapyridine affects neutrophil function.
Neutrophils play an important part in the pathogenesis of the inflammatory process in rheumatoid arthritis. Thus upon activation these cells release lysosomal enzymes and reactive oxygen radicals,2224 which can provoke tissue destruction and mediate abnormal immune reactions.25 26It has been shown that neutrophil superoxide production as well as chemotaxis elicited by the synthetic tripeptide N-formylmethionyl-leucyl-phenylalanine (fMLP) were reduced by sulphasalazine,27 28 and that this reduction might depend on sulphasalazine inhibiting the binding of fMLP to its receptors on neutrophils.27 Furthermore, sulphasalazine or sulphapyridine decreased superoxide production and lysosomal enzyme release in response to serum coated zymosan and immune complexes.2>30 Whether these last effects were due to inhibition of particle binding has not been studied. Consequently, it is unclear if sulphasalazine affects neutrophil functions merely by inhibiting binding of fMLP and particles to its receptors or ifsulphasalazine also affects intrinsic neutrophil properties. It was thus of interest to investigate further the way in which sulphasalazine and sulphapyridine affect neutrophil function. For 20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES) pH 7-4 were loaded with 0-5 FtM fura-2AM (fura-2-tetra-acetomethoxy ester) for 30 fMLP=N-formyl-methionyl-leucyl-phenylalanine;
PMA=phorbol myristate acetate.
sible. Thus cells incubated with 0-5 mM sulphapyridine after washing generated 64-1 (SEM 7-2)% superoxide upon fMLP stimulation and upon A23187 stimulation 58-1 (10-2)% superoxide compared with control cells. Sulphasalazine and sulphapyridine had no effect on basal cytochrome c reduction. In addition, neither inhibited superoxide production by a cell free generating system of xanthine plus xanthine oxidase (data not shown). Therefore sulphasalazine and sulphapyridine did not exert their inhibitory effects on oxidative metabolism by scavenging superoxide anion directly.
INCREASE OF CYTOSOLIC Ca" CONCENTRATION As superoxide production elicited by both fMLP and ionophore was inhibited by sulphasalazine and sulphapyridine we next studied a common signal transduction event essential for ligand and calcium ionophore but not for PMA elicited neutrophil function. Consequently, we measured the effect of sulphasalazine or sulphapyridine on the ability of fMLP and of a calcium ionophore, ionomycin, to induce changes in neutrophil free Ca' +. We used neutrophils loaded with fura-2, a dye that forms a fluorescent complex with Ca . An increase in fluorescence upon stimulation of cells is considered to correlate with an increase of cytosolic free Ca+. Both fMLP 0-1 imol/l and ionomycin 2 imol/l rapidly increased the fluorescence and, thus, the cytosolic Ca"+ concentration. Neutrophils at rest had a cytosolic Ca"+ concentration of 70 (SEM 9) nmol/l, which upon cell activation with fMLP increased to 401 (15) nmol/l and upon activation with ionomycin to 422 (38) nmol/l. The intention was to see ifsulphasalazine 100 pmol/l and sulphapyridine 100 pmol/l, which significantly inhibited superoxide production, inhibited this Ca" increase. Sulphasalazine 100 imol/l had a slightly yellow colour, however, which interfered with the light emission. We instead used sulphasalazine 10 iimol/l as it was not feasible to wash sulphasalazine The results showed that sulphasalazine 10 tmol/l significantly inhibited both fMLP and ionomycin induced increase of cytosolic free Ca". Sulphapyridine 100 [imolll also inhibited both responses when cells were washed after incubation and before stimulation (fig 3) .
Discussion
In this study we have shown that sulphasalazine and sulphapyridine inhibit superoxide production elicited by the tripeptide fMLP and the calcium ionophore A23187 in a dose dependent manner, and that they also inhibit mobilisation of cytosolic free Ca + induced by the same stimuli. Sulphasalazine and sulphapyridine do not, however, affect PMA elicited superoxide generation, a stimulus response coupling that is independent of increase of cytosolic free Ca++.38 39 Neutrophils can be triggered to generate superoxide anions by a variety of stimuli, including the tripeptide fMLP, calcium ionophores, and the tumour promoter PMA. The signal transduction pathways by which these stimuli activate the membrane oxidase are different, however (fig 4) . shown here might theoretically be located at any step in the stimulus response coupling. One possibility is that the drugs inhibit binding of fMLP to its receptor, which has been reported earlier for sulphasalazine. 27 The inhibition of superoxide generation may, however, not solely be attributed to inhibition of fMLP binding.
Other mechanisms are probable because sulphasalazine and sulphapyridine also reduced superoxide release by A23187. The similar doseresponse curves for the effect of sulphasalazine and sulphapyridine on superoxide generation elicited by fMLP and A23187 suggest there may be a common block. Calcium ionophores increase cytosolic free Ca"+ directly by transporting calcium into the cell, thus bypassing the initial steps for fMLP activation. The findings reported here that sulphasalazine and sulphapyridine inhibit increase of cytosolic Ca" induced by both fMLP and the calcium ionophore ionomycin indicate that they interfere with calcium mobilisation. According to earlier work, such a block of calcium redistribution may well explain the reduced oxidase activation.4 41 Further support for the theory that sulphasalazine and sulphapyridine act by interfering with calcium mobilisation is that neither substance affected superoxide generation induced by PMA. Neutrophil functions stimulated by PMA are not associated with and not dependent on a rise in the level of intracellular free Ca++.38 39 The fact that superoxide generation induced by PMA was unaffected by sulphasalazine and sulphapyridine indicates that these drugs do not impair the oxidase enzyme activity or 
